ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study

After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by t...

ver descrição completa

Detalhes bibliográficos
Autores: Domènech-Montoliu S, Puig-Barberà J, Pac-Sa MR, Vidal-Utrillas P, Latorre-Poveda M, Rio-González AD, Ferrando-Rubert S, Ferrer-Abad G, Sánchez-Urbano M, Aparisi-Esteve L, Badenes-Marques G, Cervera-Ferrer B, Clerig-Arnau U, Dols-Bernad C, Fontal-Carcel M, Gomez-Lanas L, Jovani-Sales D, León-Domingo MC, Llopico-Vilanova MD, Moros-Blasco M, Notari-Rodríguez C, Ruíz-Puig R, Valls-López S, Arnedo-Pena A
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2021
País:España
Recursos:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositório:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p11519
Acesso em linha:https://fisabio.portalinvestigacion.com/publicaciones/11519
Access Level:Acceso aberto
Palavra-chave:COVID-19
post-COVID-19
complications
symptoms
ABO blood groups
incidence
cohort
population based
id ES_30c7a7eca84d3ec5c171b9514dcecb2f
oai_identifier_str oai:fisabio.fundanetsuite.com:p11519
network_acronym_str ES
network_name_str España
repository_id_str
spelling ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort StudyDomènech-Montoliu SPuig-Barberà JPac-Sa MRVidal-Utrillas PLatorre-Poveda MRio-González ADFerrando-Rubert SFerrer-Abad GSánchez-Urbano MAparisi-Esteve LBadenes-Marques GCervera-Ferrer BClerig-Arnau UDols-Bernad CFontal-Carcel MGomez-Lanas LJovani-Sales DLeón-Domingo MCLlopico-Vilanova MDMoros-Blasco MNotari-Rodríguez CRuíz-Puig RValls-López SArnedo-Pena ACOVID-19post-COVID-19complicationssymptomsABO blood groupsincidencecohortpopulation basedAfter a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castello and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 & PLUSMN; 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24-2.27), and symptoms of fatigue (1.79, 95% CI 1.08-2.95), myalgia (2.06, 95% CI 1.10-3.84), headache (2.61, 95% CI 1.58-4.31), and disorder of vision (4.26 95% CI 1.33-13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results.MDPI2021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/11519International Journal of Environmental Research and Public HealthISSN: 16617827ISSNe: 16604601reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p115192026-06-11T12:45:17Z
dc.title.none.fl_str_mv ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
spellingShingle ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
Domènech-Montoliu S
COVID-19
post-COVID-19
complications
symptoms
ABO blood groups
incidence
cohort
population based
title_short ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_full ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_fullStr ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_full_unstemmed ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_sort ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
dc.creator.none.fl_str_mv Domènech-Montoliu S
Puig-Barberà J
Pac-Sa MR
Vidal-Utrillas P
Latorre-Poveda M
Rio-González AD
Ferrando-Rubert S
Ferrer-Abad G
Sánchez-Urbano M
Aparisi-Esteve L
Badenes-Marques G
Cervera-Ferrer B
Clerig-Arnau U
Dols-Bernad C
Fontal-Carcel M
Gomez-Lanas L
Jovani-Sales D
León-Domingo MC
Llopico-Vilanova MD
Moros-Blasco M
Notari-Rodríguez C
Ruíz-Puig R
Valls-López S
Arnedo-Pena A
author Domènech-Montoliu S
author_facet Domènech-Montoliu S
Puig-Barberà J
Pac-Sa MR
Vidal-Utrillas P
Latorre-Poveda M
Rio-González AD
Ferrando-Rubert S
Ferrer-Abad G
Sánchez-Urbano M
Aparisi-Esteve L
Badenes-Marques G
Cervera-Ferrer B
Clerig-Arnau U
Dols-Bernad C
Fontal-Carcel M
Gomez-Lanas L
Jovani-Sales D
León-Domingo MC
Llopico-Vilanova MD
Moros-Blasco M
Notari-Rodríguez C
Ruíz-Puig R
Valls-López S
Arnedo-Pena A
author_role author
author2 Puig-Barberà J
Pac-Sa MR
Vidal-Utrillas P
Latorre-Poveda M
Rio-González AD
Ferrando-Rubert S
Ferrer-Abad G
Sánchez-Urbano M
Aparisi-Esteve L
Badenes-Marques G
Cervera-Ferrer B
Clerig-Arnau U
Dols-Bernad C
Fontal-Carcel M
Gomez-Lanas L
Jovani-Sales D
León-Domingo MC
Llopico-Vilanova MD
Moros-Blasco M
Notari-Rodríguez C
Ruíz-Puig R
Valls-López S
Arnedo-Pena A
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COVID-19
post-COVID-19
complications
symptoms
ABO blood groups
incidence
cohort
population based
topic COVID-19
post-COVID-19
complications
symptoms
ABO blood groups
incidence
cohort
population based
description After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castello and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 & PLUSMN; 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24-2.27), and symptoms of fatigue (1.79, 95% CI 1.08-2.95), myalgia (2.06, 95% CI 1.10-3.84), headache (2.61, 95% CI 1.58-4.31), and disorder of vision (4.26 95% CI 1.33-13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/11519
url https://fisabio.portalinvestigacion.com/publicaciones/11519
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv International Journal of Environmental Research and Public Health
ISSN: 16617827
ISSNe: 16604601
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405567913558016
score 15,812429

Registros relacionados